Q2 2016 13F Holders as of 6/30/2016
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
194M
-
Number of holders
-
386
-
Total 13F shares, excl. options
-
160M
-
Shares change
-
-3.11M
-
Total reported value, excl. options
-
$12.4B
-
Value change
-
-$243M
-
Put/Call ratio
-
0.99
-
Number of buys
-
198
-
Number of sells
-
-153
-
Price
-
$77.80
Significant Holders of BIOMARIN PHARMACEUTICAL INC - Common Stock, par value $0.001 per share (BMRN) as of Q2 2016
464 filings reported holding BMRN - BIOMARIN PHARMACEUTICAL INC - Common Stock, par value $0.001 per share as of Q2 2016.
BIOMARIN PHARMACEUTICAL INC - Common Stock, par value $0.001 per share (BMRN) has 386 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 160M shares
of 194M outstanding shares and own 82.58% of the company stock.
Largest 10 shareholders include Capital Research Global Investors (15.9M shares), VANGUARD GROUP INC (11.4M shares), FMR LLC (11.1M shares), SANDS CAPITAL MANAGEMENT, LLC (10.9M shares), JENNISON ASSOCIATES LLC (9.05M shares), PRIMECAP MANAGEMENT CO/CA/ (7.32M shares), BAKER BROS. ADVISORS LP (4.81M shares), BlackRock Institutional Trust Company, N.A. (3.92M shares), BlackRock Fund Advisors (3.74M shares), and PRICE T ROWE ASSOCIATES INC /MD/ (3.53M shares).
This table shows the top 386 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.